防止Junctophilin-2的特定部位的calpain蛋白溶解 防止压力诱导的刺激-收缩解离和心力衰竭的发展
在PubMed上查看摘要
概括
此摘要是机器生成的。预防Junctophilin-2 (JP2) 裂变可以防止心力衰竭 (HF). 抗疼痛的JP2 (JP2<sup>CR</sup>) 保持心脏功能,改善处理,为HF提供潜在的治疗策略.
科学领域
- 心血管生物学
- 分子心脏病学
- 心脏衰竭的病理生理学
背景情况
- 心力衰竭 (HF) 涉及刺激-收缩 (E-C) 合的中断,导致异常的 (Ca2+) 处理和心脏功能障碍.
- 克托菲林-2 (JP2) 对于E-C合至关重要,但在HF中被卡尔帕因分裂,破坏了E-C合和横管完整性.
- 目前尚不清楚防止JP2裂变是否可以在体内保护心脏免受压力诱导的重塑.
研究的目的
- 调查防止JP2的卡尔潘裂变是否足以在体内保护心脏免受压力诱导的病变重塑.
- 评估针对心力衰竭的JP2裂变的治疗潜力.
主要方法
- 通过删除主要的calpain分裂部位,生成了耐卡尔的JP2敲入小鼠 (JP2<sup>CR</sup>).
- 在实验室和用异二醇治疗的心肌细胞中评估了JP2裂变.
- 在横向大动脉收缩 (TAC) 后评估JP2<sup>CR</sup>和野生型小鼠的心脏结果,使用心声学,组织学和RNA测序.
- 在已确定的心脏功能障碍的小鼠中使用JP2进行了腺相关病毒 (AAV) 基因治疗.
主要成果
- 在接受TAC的JP2心肌细胞和心脏中,calpain阻断了JP2蛋白质分解.
- JP2<sup>CR</sup>的心脏表现出改善的Ca<sup>2+</sup>平衡,横管组织,以及抵抗压力过载的压力.
- 与野生类型小鼠相比,JP2<sup>CR</sup>减轻了心脏功能障碍,高,肺,纤维化和有害的基因表达变化.
- JP2<sup>CR</sup>基因治疗减缓了HF的进展,并且优于野生型JP2治疗.
结论
- 通过防止卡尔巴因裂变来保护JP2-依赖的E-C合,可以显著地保护心脏免受压力诱导的损伤和HF.
- 通过基因疗法向JP2的主要calpain裂变部位是治疗心力衰竭的一种有前途的精准医学方法.
相关概念视频
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

